Multi-site investigation of strategies for the implementation of CYP2C19 genotype-guided antiplatelet therapy

CYP2C19 genotype-guided antiplatelet therapy following percutaneous coronary intervention is increasingly implemented in clinical practice. However, challenges such as selecting a testing platform, communicating test results, building clinical decision support processes, providing patient and provid...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Pharmacol Ther
Autors principals: Empey, Philip E., Stevenson, James M., Tuteja, Sony, Weitzel, Kristin W., Angiolillo, Dominick J., Beitelshees, Amber L., Coons, James C., Duarte, Julio D., Franchi, Francesco, Jeng, Linda J.B., Johnson, Julie A., Kreutz, Rolf P, Limdi, Nita A., Maloney, Kristin A., Obeng, Aniwaa Owusu, Peterson, Josh F., Petry, Natasha, Pratt, Victoria M., Rollini, Fabiana, Scott, Stuart A., Skaar, Todd C., Vesely, Mark R., Stouffer, George A., Wilke, Russell A., Cavallari, Larisa H., Lee, Craig R.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6019555/
https://ncbi.nlm.nih.gov/pubmed/29280137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1006
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars